SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
14,766Targets
453Trials
84Drugs
7Datasets
6,987Sources
64,683Claims
72,052Evidence
29,649Hypotheses
DRUGphase1aso

biogen-ionis novel aso

Mechanism

Next-generation antisense oligonucleotide for SMA. Novel ASO with improved potency or delivery.

Related claims (0)

No claims matched “biogen-ionis novel aso” in free-text search.

Off-Target Findings (0)

No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.

Login → Command Center